Literature DB >> 10082724

Postmarketing surveillance study of a non-chlorofluorocarbon inhaler. Such studies initiated by manufacturer are designed to promote product.

M G Bamber.   

Abstract

Mesh：

Year:  1999        PMID： 10082724      PMCID： PMC1115235     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Difficulties with CFC-free salbutamol inhaler.

Authors:  M G Bamber
Journal:  Lancet       Date:  1996 Dec 21-28       Impact factor: 79.321

2.  Guidelines for company-sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993)

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1994-08       Impact factor: 4.335

3.  Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines.

Authors:  J G Ayres; C D Frost; W F Holmes; D R Williams; S M Ward
Journal:  BMJ       Date:  1998-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.